Samsung Medical Center
| كوريا الجنوبية | تركيا | إسبانيا | |
| زرع نخاع العظم | من $55,000 | من $36,000 | من $71,782 |
| زراعة نخاع العظم الذاتي | من $42,000 | من $31,500 | من $40,000 |
| زراعة النخاع العظمي من متبرع قريب | من $75,000 | من $65,000 | من $13,928 |
| زراعة النخاع العظمي من متبرع غير قريب | من $145,000 | من $80,000 | من $150,000 |
| العلاج بالخلايا التائية ذات مستقبل المستضد الخيمري | من $385,000 | من $150,000 | من $330,000 |
Bookimed لا يضيف رسوماً إضافية على أسعار علاج سرطان الغدد الليمفاوية. الأسعار مأخوذة من قوائم الأسعار الرسمية للعيادات. تدفع مباشرة في العيادة مقابل علاجك عند وصولك إلى البلد.
Bookimed ملتزم بسلامتك. نحن نعمل فقط مع المؤسسات الطبية التي تحافظ على معايير دولية عالية في علاج سرطان الغدد الليمفاوية ولديها التراخيص اللازمة لخدمة المرضى الدوليين في جميع أنحاء العالم.
Bookimed يقدم مساعدة خبراء مجانية. منسق طبي شخصي يدعمك قبل وأثناء وبعد العلاج، ويحل أي مشاكل. لن تكون وحيداً أبداً في رحلة علاج سرطان الغدد الليمفاوية.
كتب بواسطة Halina Shubala
كتب بواسطة Anna Leonova
Lymphoma chemotherapy in Korea achieves remission rates between 85% and 90% for early-stage patients. Specialized clinical studies report an 87.6% complete remission rate for Hodgkin’s lymphoma. Aggressive B-cell subtypes like DLBCL reach approximately 84% remission. Major Seoul centers use advanced protocols for these results.
Bookimed Expert Insight: Data shows a high concentration of expertise in Seoul. Facilities like Samsung Medical Center and Severance Hospital manage over 2 million patients annually. These high-volume centers report remission rates comparable to Western benchmarks. This is due to their rapid adoption of digital systems. Seoul National University Hospital has been fully digitalized since 2004. This digital accuracy helps specialists refine chemotherapy dosing for complex lymphoma subtypes.
Patient Consensus: Patients note that Korean protocols are intensive. They emphasize the importance of reaching clear PET scans early in the treatment process.
CAR T-cell therapy is available for lymphoma patients at several licensed medical centers in South Korea. Major institutions provide approved therapies like Kymriah and Yescarta for relapsed or refractory diffuse large B-cell lymphoma. Local centers often collaborate on domestic clinical trials to expand treatment accessibility.
Bookimed Expert Insight: While South Korea ranks eighth globally in medical requests, its oncology infrastructure is exceptionally concentrated. Samsung Medical Center and Severance Hospital manage over 6,000,000 patients combined each year. This massive volume allows these centers to maintain dedicated CAR T-cell units. Such specialization often leads to smoother logistics for complex cellular processing than smaller regional hubs.
Patient Consensus: Patients note it is important to confirm eligibility through telemedicine before traveling for aggressive B-cell lymphoma treatments. Many highlight that coordinating professional translation and post-treatment monitoring is essential for a smooth experience at Seoul hospitals.
Leading centers for lymphoma treatment in South Korea include Samsung Medical Center, Asan Medical Center, and Seoul National University Hospital. These Seoul-based institutions provide advanced therapies like CAR-T cell therapy and hematopoietic stem cell transplants. Most facilities hold JCI or KOIHA accreditations for oncology excellence.
Bookimed Expert Insight: Patient volume often indicates specialized expertise in Korea. Severance Hospital and Samsung Medical Center handle high annual patient counts, exceeding 2,000,000 people each. Our data shows these large academic centers often centralize clinical trials for immunotherapy. Choosing a high-volume center in Seoul typically ensures access to newer drug-based protocols not available regionally.
Patient Consensus: Patients emphasize seeking second opinions at multiple Seoul-based clinics to confirm aggressive lymphoma diagnoses. Many note that major teaching hospitals provide better English-speaking support for international oncology coordination.
Integrating Western lymphoma therapies with Korean Traditional Medicine (KTM) is a standard practice in Seoul medical centers. Specialized hospitals combine chemotherapy or immunotherapy with acupuncture and herbal medicine. These protocols manage side effects like neuropathy and fatigue while supporting immune function during rigorous treatment cycles.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital use digital systems like BESTcare to coordinate complex treatments for millions of patients. Our data shows that top-tier Seoul facilities often have KTM-integrated oncology referrals nearby. Patients should choose JCI-accredited hospitals that offer multidisciplinary tumor boards. These boards ensure traditional herbs do not interfere with advanced treatments like CAR T-cell therapy.
Patient Consensus: Patients note that getting oncologist approval for mild herbal teas often helps with post-chemo recovery and nausea. Many advise sticking strictly to hospital-approved herbs rather than over-the-counter options to avoid dangerous drug interactions.
Patients must bring complete medical records, including pathology slides, digital imaging, and detailed treatment logs. These documents ensure accurate diagnostic review and prevent treatment delays. South Korean cancer centers require recent scans and certified translations to confirm lymphoma staging and previous chemotherapy cycles.
Bookimed Expert Insight: Advanced centers like Samsung Medical Center and Asan Medical Center handle massive patient volumes, often exceeding 180,000 annually. This high traffic means diagnostic departments prioritize digital records over paper files for faster processing. Patients should bring three physical copies of all records, but keeping everything on a USB drive is the most efficient way to ensure Korean oncologists can integrate your history into their digital BESTcare systems immediately.
Patient Consensus: Patients emphasize that bringing physical pathology slides is essential to avoid repetitive biopsies that can cost $2,000. It is also important to have all files translated into Korean or English at least four weeks before traveling.
Seoul and Incheon serve as the primary hubs for lymphoma care in South Korea. These cities host Joint Commission International-accredited centers. They specialize in CAR T-cell therapy and bone marrow transplants. Patients access advanced diagnostics like PET-CT and cytogenetic analysis at these facilities.
Bookimed Expert Insight: Seoul centers demonstrate high-volume expertise rarely seen elsewhere. Asan Medical Center serves over 11,000 outpatients daily. This massive scale allows clinics like Seoul National University Bundang Hospital to implement digital systems that reduce medical errors. If seeking complex transplants, focusing on these high-capacity Seoul institutions ensures access to larger hematology teams.
Patient Consensus: Patients note that Seoul centers often provide faster treatment starts for aggressive lymphomas compared to US facilities. They frequently mention the benefit of having English-speaking coordinators at Samsung Medical Center to help navigate complex therapy schedules.